RIGA, Latvia, Feb. 17, 2026 /PRNewswire/ — Mintos, a European multi-asset investment platform, has taken a major step in its long-term strategy by initiating theRIGA, Latvia, Feb. 17, 2026 /PRNewswire/ — Mintos, a European multi-asset investment platform, has taken a major step in its long-term strategy by initiating the

Mintos pursues ECB banking licence

2026/02/17 16:30
3 min read

RIGA, Latvia, Feb. 17, 2026 /PRNewswire/ — Mintos, a European multi-asset investment platform, has taken a major step in its long-term strategy by initiating the process to pursue a banking licence from the European Central Bank (ECB). Obtaining a banking licence would strengthen investor trust, expand Mintos’ financial infrastructure, and support sustainable growth across Europe.

Founded ten years ago as a peer-to-peer lending marketplace, Mintos has evolved into a regulated, multi-asset investment platform serving nearly 700,000 registered investors and managing over €800 million in assets. Over the past two years, the company has expanded its product offering to include fractional bonds, ETF portfolios, real estate, and Smart Cash, while completing its rollout across all EU markets.

Pursuing an ECB banking licence represents the next logical phase of Mintos’ development. The licence, subject to regulatory approval, will provide access to deposit-based funding and create a foundation for offering lending and other banking products directly to customers, significantly expanding the platform’s long-term product offering.

The banking licence also enables deposit protection of up to €100,000* and would give Mintos greater control over key parts of its infrastructure, including custody, clearing, and settlement. Together, these capabilities aim to further strengthen investor confidence and support sustainable, long-term growth.

Pursuing an ECB banking licence is a strategic decision that builds on the strong regulatory and operational foundation we have already established,” said Martins Sulte, CEO and Co-Founder of Mintos. “It enables us to expand what we can offer our investors, combining the trust and stability of a bank with the innovation of a modern investment platform.

Mintos expects the banking licence process to take approximately 12 to 18 months, subject to regulatory approvals.

The strategic shift is supported by Mintos’ broader capital-raising efforts, including the successful completion of a recent funding round on the Mintos platform. In this round, nearly 6,000 Mintos investors committed a total of €2.8 million, marking an important first step in funding the company’s next phase.

*Any future deposit-related products would be subject to applicable deposit guarantee frameworks, where relevant and if legally available.

This press release contains forward-looking statements and strategic intentions. Any application for, or granting of, a banking licence is subject to regulatory approval and cannot be guaranteed. References to potential future products or services do not constitute an offer or commitment and are subject to applicable regulatory requirements and business decisions.

Logo – https://mma.prnewswire.com/media/2819635/5796385/Mintos_Logo.jpg

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/mintos-pursues-ecb-banking-licence-302687557.html

SOURCE Mintos

Market Opportunity
Major Logo
Major Price(MAJOR)
$0.07915
$0.07915$0.07915
-1.72%
USD
Major (MAJOR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Knocking Bitcoin's lack of yield shows your ‘Western financial privilege’

Knocking Bitcoin's lack of yield shows your ‘Western financial privilege’

                                                                               Macro analyst Luke Gromen’s comments come amid an ongoing debate over whether Bitcoin or Ether is the more attractive long-term option for traditional investors.                     Macro analyst Luke Gromen says the fact that Bitcoin doesn’t natively earn yield isn’t a weakness; it’s what makes it a safer store of value.“If you’re earning a yield, you are taking a risk,” Gromen told Natalie Brunell on the Coin Stories podcast on Wednesday, responding to a question about critics who dismiss Bitcoin (BTC) because they prefer yield-earning assets.“Anyone who says that is showing their Western financial privilege,” he added.Read more
Share
Coinstats2025/09/18 14:22
Ronin Price Prediction 2026-2030: A Strategic Deep Dive into RON’s Critical Juncture

Ronin Price Prediction 2026-2030: A Strategic Deep Dive into RON’s Critical Juncture

BitcoinWorld Ronin Price Prediction 2026-2030: A Strategic Deep Dive into RON’s Critical Juncture As the blockchain gaming sector enters a pivotal phase of maturation
Share
bitcoinworld2026/02/17 19:30
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11